Search results
25 cze 2019 · This guideline covers diagnosing and managing hypertension (high blood pressure), including pre-eclampsia, during pregnancy, labour and birth. It also includes advice for
Hypertensive disorders during pregnancy carry risks for the woman and remain a cause of maternal death. The mortality rate from hypertensive related causes has remained stable at 6 per 100,000 maternities in 2014-16 and 2017-19 (MBRRACE-UK, 2021).
hypertensive disorders that occur during pregnancy present after 20 weeks gestation. New hypertension can occur without significant proteinuria (gestational hypertension) or with significant proteinuria (pre-eclampsia).
Guidance. We use the best available evidence to develop recommendations that guide decisions in health, public health and social care. Published guidance on this topic (6) New in the last 6 months (4) Updated in the last 6 months (0) In development (2) Quality standards. Set out priority areas for quality improvement in health and social care.
NICE guideline NG133. Supplement 1. June 2019. FINAL. This methods chapter was developed by the National Guideline Alliance, hosted by the Royal College of Obstetricians and Gynaecologists. Methods. Disclaimer. The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available.
Hypertension in pregnancy. Last revised in May 2022. Management. Scenario: Pre-eclampsia. Scenario: Pre-existing hypertension, or hypertension before 20 weeks. Scenario: New hypertension after 20 weeks. Scenario: Proteinuria and no hypertension after 20 weeks. Scenario: Postpartum follow-up. Prescribing information. Aspirin. Labetalol. Methyldopa.
SOMANZ HYPERTENSION IN PREGNANCY GUIDELINE 2023 3 Disclaimer This guideline document is based upon literature searches last conducted in December 2020, and updated in December 2022. It is designed to assist with decision-making in matter related to the care of women with hypertension in pregnancy.
